Fr. 298.00

Cannabinoids as Therapeutics

Inglese · Copertina rigida

Spedizione di solito entro 6 a 7 settimane

Descrizione

Ulteriori informazioni

In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research.

Sommario

Cannabis in India: ancient lore and modern medicine.- Cannabinoid chemistry: an overview.- Cannabidiol as a potential medicine.- Endocannabinoids and regulation of fertility.- Cannabinoids in neurodegeneration and neuroprotection.- Role of the endocannabinoid system in learning and memory.- Cannabinoids and anxiety.- Cannabinoid targets for pain therapeutics.- Potential use of cannabimimetics in the treatment of cancer.- Cannabinoids: effects on vomiting and nausea in animal models.- The skeleton: stone bones and stoned heads?.- Cannabinoids and drugs of abuse.- Cannabinoids in appetite and obesity.- The development of Sativex® - a natural cannabis-based medicine.

Riassunto

In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research.

Dettagli sul prodotto

Con la collaborazione di R. Mechoulam (Editore), Raphae Mechoulam (Editore), Raphael Mechoulam (Editore)
Editore Springer, Basel
 
Lingue Inglese
Formato Copertina rigida
Pubblicazione 27.05.2005
 
EAN 9783764370558
ISBN 978-3-7643-7055-8
Pagine 268
Dimensioni 175 mm x 245 mm x 22 mm
Peso 644 g
Illustrazioni X, 268 p.
Serie Milestones in Drug Therapy
Milestones in Drug Therapy
Categorie Scienze naturali, medicina, informatica, tecnica > Medicina > Farmacia

Physiologie, Psychiatrie, B, Neurologie und klinische Neurophysiologie, Neurowissenschaften, Research, Neurology, HUMAN PHYSIOLOGY, PHYSIOLOGY, Neuroscience, Psychiatry, Obesity, Neurology & clinical neurophysiology, Neurosciences, Pharmacology, Rheumatoid arthritis, Biomedical and Life Sciences, Pharmacology/Toxicology

Recensioni dei clienti

Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.

Scrivi una recensione

Top o flop? Scrivi la tua recensione.

Per i messaggi a CeDe.ch si prega di utilizzare il modulo di contatto.

I campi contrassegnati da * sono obbligatori.

Inviando questo modulo si accetta la nostra dichiarazione protezione dati.